🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎯 Our investigational clinical candidates, VIR-5818 and VIR-5500, target two proteins with crucial roles in cancer: HER2 and PSMA, respectively. Data shows encouraging signs of anti-tumor activity in patients who need new options to treat their #cancers. bit.ly/4gKXbxX

📣The future leaders of #biotech are here! Our 2025 SF State Mentorship Program connects #STEM students with resources for biotech careers. We're fortunate to collaborate with the next generation of innovators, whose ideas are helping us build a more inclusive future in science!

To participate in a clinical trial takes a leap of faith for people living with cancer, their families and their physicians. This #WorldCancerDay, we thank everyone in our clinical studies as we work to offer new hope for people living with solid tumors. #UnitedbyUnique Union for International #CancerControl

Ramy Farid, Board of Directors at #VirBiotechnology, joined for a Fireside Chat about driving meaningful change in today’s #AI-driven landscape. Learn how we’re accelerating the discovery of lead drug candidates with the help of our AI engine, #dAIsY™. bit.ly/4f490Oy

Meet our Chief Scientific Officer Jennifer Towne, one of the brilliant minds driving innovation at #VirBiotechnology! This #InternationalDayofWomenandGirlsinScience, we’re proud to celebrate the achievements of Jennifer and other inspiring women on our teams.

We were honored to have a person living with hepatitis delta, along with Dr. Nghiem Ha, Assistant Professor of Medicine at UC San Francisco Viral Hepatitis Center, courageously share their personal experiences in navigating the devastating disease with us.

Join members of the executive team as they participate in a fireside chat to discuss all things #VirBiotechnology at the TD Cowen 45th Annual Health Care Conference on Tues. Mar. 4 at 8:50 a.m. PT/11:50 a.m. ET. bit.ly/3Qws8u9

👉#VirBiotechnology will provide a corporate update and report Q4 & Full Year 2024 financial results on Wed., Feb. 26, at 4:30 p.m. ET. Join us for our investor conference call to hear about our progress and potential for significant advancement in 2025. bit.ly/3XgaQ8m

📢#VirBiotechnology News: Today our Chief Executive Officer Marianne D. De Backer, MSc, PhD, MBA, shares our Q4 and Full Year 2024 financial results. As we enter 2025, we are poised for significant advancement: bit.ly/3QBPWgh #Earnings

As we look back at this #BlackHistoryMonth, we want to extend a huge thank you to Studio5 for hosting an insightful discussion about the powerful contributions of Black and African American people throughout history. At #VirBiotechnology, we cherish these learning moments.

Virites showed their support for #IWD2025 this week and called for us all to #AccelerateAction. Let’s continue to support and empower women to achieve their goals in #STEM and drive meaningful change together!

🚀Phase 3 ECLIPSE registrational program in chronic #hepatitis #delta initiated. This is an important step forward on our path to delivering a highly effective treatment for people living with chronic hepatitis delta. Read more here➡️ bit.ly/41NZHx1

📣Check out #VirBiotechnology on the iconic NASDAQ MarketSite Tower in the heart of Times Square shining a spotlight on the initiation of our Phase 3 ECLIPSE Registrational Program in chronic hepatitis delta! Read more here ➡️ bit.ly/41NZHx1

💡We are shining a light on some of our incredible leaders who drive scientific innovation, inspire teams and steer the future of #VirBiotechnology. We’re proud and grateful to be #MovingForwardTogether with them! Learn about our broader leadership team ➡️ bit.ly/427dnn9

#VirBiotechnology will be at #EASLCongress 2025 to share the latest updates of our ongoing work in #hepatitisDelta and #hepatitisB. Find out more here ➡️ ow.ly/Nuj350VH4Cl

🧬 The #SwissBiotechDay is a prime event for the life sciences in Switzerland! Join #VirBiotechnology to learn more about how we are powering the #immune system to transform lives. Check all the details here ➡️ ow.ly/R9IE50VIZsR

👉 #VirBiotechnology will provide a corporate update and report Q1 financial results on Wed., May 7, at 1:30 p.m. PT/4:30 p.m. ET. Join us for our investor conference call. ow.ly/Gw7y50VKUbX #Earnings